The refit model for end-stage liver disease-Na is not a better predictor of mortality than the refit model for end-stage liver disease in patients with cirrhosis and ascites
Jun Jae Kim, Jeong Han Kim, Ja Kyung Koo, Yun Jung Choi, Soon Young Ko, Won Hyeok Choe, So Young Kwon
Clin Mol Hepatol. 2014;20(1):47-55.   Published online 2014 Mar 26     DOI: https://doi.org/10.3350/cmh.2014.20.1.47
Citations to this article as recorded by Crossref logo
The diagnostic accuracy of ascitic calprotectin for the early diagnosis of spontaneous bacterial peritonitis: systematic review and meta-analysis
Alexandros Hadjivasilis, Alexander Tzanis, Kalliopi J. Ioakim, Ioanna Poupoutsi, Aris P. Agouridis, Panayiotis Kouis
European Journal of Gastroenterology & Hepatology.2021; 33(3): 312.     CrossRef
Influence of preoperative sodium concentration on outcome of patients with hepatitis B virus cirrhosis after liver transplantation
Peijie Wang, Gang Huang, Ngalei Tam, Chenglin Wu, Shunjun Fu, Bridget P. Hughes, Linwei Wu, Xiaoshun He
European Journal of Gastroenterology & Hepatology.2016; 28(10): 1210.     CrossRef